LGALS1 and Alzheimer disease: This corresponds to the findings we have already reported for canine AD-MSC and platelet lysate (14), and is consistent with studies that already demonstrated that hPL does not adversely alter the genetic stability of human BM- and AD-MSC (23, 24, 58).